Related content

Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer

By Marret H.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 17-23

Springer Publishing Company

Access to resources Recommend Favorite

Resection Margin and Recurrence-Free Survival After Liver Resection of Colorectal Metastases

By Muratore Andrea   Ribero Dario   Zimmitti Giuseppe   Mellano Alfredo   Langella Serena   Capussotti Lorenzo  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1324-1329

Springer Publishing Company

Access to resources Recommend Favorite

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

By Ohno S.   Chow L.   Sato N.   Masuda N.   Sasano H.   Takahashi F.   Bando H.   Iwata H.   Morimoto T.   Kamigaki S.   Nakayama T.   Nakamura S.   Kuroi K.   Aogi K.   Kashiwaba M.   Yamashita H.   Hisamatsu K.   Ito Y.   Yamamoto Y.   Ueno T.   Fakhrejahani E.   Yoshida N.   Toi M.  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 69-80

Springer Publishing Company

Access to resources Recommend Favorite

A signature of immune function genes associated with recurrence-free survival in breast cancer patients

By Ascierto Maria  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 871-880

Springer Publishing Company

Access to resources Recommend Favorite

Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia

By Santisteban Marta  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 431-437

Springer Publishing Company

Access to resources Recommend Favorite